查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448495

人类微生物组市场：趋势、预测、竞争分析 [2024-2030]

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

人类微生物组市场趋势与预测

预计到 2028 年，全球人类微生物组市场将达到约 25 亿美元，2024 年至 2030 年的复合年增长率为 17.8%。该市场的主要驱动力是对人类微生物组治疗的日益关注以及总体基因体学和次世代定序仪技术进步的不断扩大。由于医疗产业的机会，全球人类微生物组市场的未来充满希望。

人类微生物组市场的新兴趋势

对产业动态有直接影响的新兴趋势包括使用细菌微生物组进行癌症治疗以及引入下一代益生菌微生物衍生分子用于肥胖治疗。

人类微生物组市场洞察

  • Lucintel 预计，由于健康问题日益严重、人们对营养/饮食与健康之间关係的认识不断提高，以及益生菌市场对乳製品和其他食品的渗透率不断提高，益生菌将成为预测期内最大的细分市场。
  • 随着人们越来越意识到抗生素使用对自然菌丛的负面影响（例如菌丛失调），感染疾病变得越来越普遍，这凸显了针对特定细菌的治疗方法对感染疾病的需求，预计传染病病仍将是最大的疾病类型。
  • 由于与文明病盛行率不断上升、预防保健意识不断增强、微生物组研究资金的可用性以及益生菌产品的接受度不断提高，预计北美在预测期内仍将是最大的地区。由于生活方式的改变以及对人类微生物组治疗方法日益浓厚的兴趣，导致慢性病增加，预计亚太地区在预测期内将出现最高的增长。

常问问题

Q1.市场规模为：

答：到 2028 年，全球人类微生物组市场预计将达到 25 亿美元。

Q2.市场成长预测是多少：

答：2024年至2030年，人类微生物组市场预计将以17.8%的复合年增长率成长。

Q3. 影响市场成长的关键驱动因素是：

答：这个市场的主要驱动力是对人类微生物组治疗的日益关注以及总体基因体学和次世代定序仪的技术进步。

Q4. 人类微生物组的主要应用或最终用途产业有哪些？

答：治疗和诊断是人类微生物组的主要用途。

Q5.人类微生物组市场有哪些新趋势？

答：对产业动态有直接影响的新兴趋势包括使用细菌微生物组来治疗癌症以及采用下一代益生菌微生物衍生分子来治疗肥胖。

Q6. 涉及人类微生物组的主要企业有哪些？

答：人类微生物组的主要企业是：

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Q7. 人类微生物组产品领域最大的未来是什么？

答： 食品预计益生菌在我们预测中仍将是最大的产品领域。

问题 8：未来五年，哪个地区的人类微生物组市场预计成长最大？

答：北美仍然是最大的，亚太地区预计将在未来五年内经历最高的成长。

Q9. 可以客製化报告吗？

答：是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章 市场背景及分类

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势和预测
  • 全球人类微生物组市场趋势及预测
  • 按产品分類的全球人类微生物组市场
    • 益生元
    • 益生菌
    • 食品
    • 医疗食品
    • 药品
  • 按疾病类型分類的全球人类微生物组市场
    • 传染性的
    • 新陈代谢/内分泌
    • 癌症
    • 血
    • 神经系统
  • 按研究技术分類的全球人类微生物组市场
    • 蛋白质体学
    • 代谢体学
    • 基因组学
  • 全球人类微生物组市场（按应用）
    • 治疗
    • 诊断

第四章 区域市场趋势及预测分析

  • 全球人类微生物组市场（按地区）
  • 北美人类微生物组市场
  • 欧洲人类微生物组市场
  • 亚太人类微生物组市场
  • 其他地区的人类微生物组市场

第五章 竞争分析

  • 产品系列分析
  • 市场占有率分析
  • 地理范围
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球人类微生物组市场成长机会（按产品）
    • 按疾病类型分類的全球人类微生物组市场成长机会
    • 研究科技的全球人类微生物组市场成长机会
    • 全球人类微生物组市场成长机会（按应用）
    • 按地区分類的全球人类微生物组市场成长机会
  • 全球人类微生物组市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球人类微生物组市场的产能
    • 全球人类微生物组市场的合併、收购和合资企业

第七章主要企业概况

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Yakult Hoshna
  • Merck & Co
  • Second Genome
  • Metabiomics Corporation .
简介目录

Human Microbiome Market Trends and Forecast

The future of the global human microbiome market looks promising with opportunities in the healthcare industry. The global human microbiome market is expected to reach an estimated $2.5 billion by 2028 with a CAGR of 17.8% from 2024 to 2030.The major drivers for this market are increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing.

Emerging Trends in the Human Microbiome Market

Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.

A total of 119 figures / charts and 99 tables are provided in this 209-page report to help in your business decisions. A sample figure with some insights is shown below.

Human Microbiome Market by Segment

In this market, therapeutics is the largest application market, whereas probiotics is the largest market by product type.

The study includes trends and forecast for the global human microbiome market by product, disease type, research technology, application, and region as follows:

Human Microbiome By Product [Value ($M) from 2018 to 2030]:

  • Prebiotics
  • Probiotics
  • Food
  • Medical Food
  • Drugs

Human Microbiome By Disease Type [Value ($ Million) from 2018 to 2030]:

  • Infectious
  • Metabolic/ Endocrine
  • Cancer
  • Blood
  • Neurological

Human Microbiome By Research Technology [Value ($ Million) from 2018 to 2030]:

  • Proteomics
  • Metabolomics
  • Genomics

Human Microbiome By Application [Value ($ Million) from 2018 to 2030]:

  • Therapeutics
  • Diagnostics

Human Microbiome By Region [Value ($ Million from 2018 to 2030]:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
  • ROW
    • Brazil

List of Human Microbiome Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies human microbiome companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the human microbiome companies profiled in this report include.

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Human Microbiome Market Insights

  • Lucintel forecasts that probiotics will remain the largest segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.
  • Infectious disease will remain the largest disease type over the forecast period due to increasing cognizance of the negative effects of antibiotic use on the natural flora (such as disruptions), which has highlighted the need for specific bacterial-targeted therapies for infectious diseases.
  • North America will remain the largest region over the forecast period due to increasing incidence of lifestyle-related diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products. APAC is expected to witness the highest growth over the forecast period due rising chronic diseases caused by changes in lifestyle and growing interest in human microbiome treatment approaches.

Features of the Human Microbiome Market

  • Market Size Estimates: Global human microbiome market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
  • Segmentation Analysis: Global human microbiome market size by product, disease type, research technology, application, and region in terms of value.
  • Regional Analysis: Global human microbiome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, disease type, research technology, application, and region for the global human microbiome market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human microbiome market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the human microbiome market size?

Answer:The global human microbiome market is expected to reach an estimated $2.5 billion by 2028.

Q2. What is the growth forecast for human microbiome market?

Answer:The human microbiome market is expected to grow at a CAGR of 17.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the human microbiome market?

Answer: The major drivers for this market are increasing focus on human microbiome therapies and technological advancements in metagenomics and next-generation sequencing.

Q4. What are the major applications or end use industries for human microbiome?

Answer:Therapeutics and Diagnostics are the major applications for human microbiome

Q5. What are the emerging trends in human microbiome market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.

Q6. Who are the key human microbiome companies?

Answer:Some of the key human microbiome companies are as follows:

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Q7.Which human microbiome product segment will be the largest in future?

Answer: Lucintel forecasts that probiotics will remain the largest product segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.

Q8: In human microbiome market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region and Asia Pacific expected to witness the highest growth over next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising growth opportunities for the global human microbiome market by product (prebiotics, probiotics, food, medical food, and drugs), disease type (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), application (therapeutics and diagnostics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human microbiome market?
  • Q.5 What are the business risks and threats to the global human microbiome market?
  • Q.6 What are the emerging trends in this human microbiome market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the human microbiome market?
  • Q.8 What are the new developments in the human microbiome market? Which companies are leading these developments?
  • Q.9 Who are the major players in the human microbiome market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the human microbiome market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the global human microbiome market?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Human Microbiome Market Trends and Forecast
  • 3.3: Global Human Microbiome Market by Product
    • 3.3.1: Prebiotics
    • 3.3.2: Probiotics
    • 3.3.3: Food
    • 3.3.4: Medical Food
    • 3.3.5: Drugs
  • 3.4: Global Human Microbiome Market by Disease Type
    • 3.4.1: Infectious
    • 3.4.2: Metabolic/Endocrine
    • 3.4.3: Cancer
    • 3.4.4: Blood
    • 3.4.5: Neurological
  • 3.5: Global Human Microbiome Market by Research Technology
    • 3.5.1: Proteomics
    • 3.5.2: Metabolomics
    • 3.5.3: Genomics
  • 3.6: Global Human Microbiome Market by Application
    • 3.6.1: Therapeutics
    • 3.6.2: Diagnostics

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Human Microbiome Market by Region
  • 4.2: North American Human Microbiome Market
    • 4.2.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.2.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.2.4: Market by Application: Therapeutics and Diagnostics
    • 4.2.5: The US Human Microbiome Market
    • 4.2.6: Canadian Human Microbiome Market
    • 4.2.7: Mexican Human Microbiome Market
  • 4.3: European Human Microbiome Market
    • 4.3.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.3.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.3.4: Market by Application: Therapeutics and Diagnostics
    • 4.3.5: Human Microbiome Market of the United Kingdom
    • 4.3.6: German Human Microbiome Market
    • 4.3.7: French Human Microbiome Market
    • 4.3.8: Italian Human Microbiome Market
    • 4.3.9: Spanish Human Microbiome Market
  • 4.4: APAC Human Microbiome Market
    • 4.4.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.4.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.4.4: Market by Application: Therapeutics and Diagnostics
    • 4.4.5: Chinese Human Microbiome Market
    • 4.4.6: Japanese Human Microbiome Market
    • 4.4.7: Indian Human Microbiome Market
  • 4.5: ROW Human Microbiome Market
    • 4.5.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.5.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.5.4: Market by Application: Therapeutics and Diagnostics
    • 4.5.5: Brazilian Human Microbiome Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Geographical Reach
  • 5.4: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
    • 6.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Human Microbiome Market by Research Technology
    • 6.1.4: Growth Opportunities for the Global Human Microbiome Market by Application
    • 6.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
  • 6.2: Emerging Trends in the Global Human Microbiome Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Human Microbiome Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market

7. Company Profiles of Leading Players

  • 7.1: Enterome
  • 7.2: Seres Therapeutics
  • 7.3: 4D Pharma
  • 7.4: DuPont
  • 7.5: Vedanta Biosciences
  • 7.6: Osel
  • 7.7: Yakult Hoshna
  • 7.8: Merck & Co
  • 7.9: Second Genome
  • 7.10: Metabiomics Corporation .